Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06472284 · ClinicalTrials.gov registry record · NA

TetraGraph in Rocuronium Infusions

A NA study of Surgery, sponsored by Joseph D. Tobias.

Active
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06472284 is a NA study of Surgery that is active but no longer recruiting, run by Joseph D. Tobias. The registered enrollment target is 50 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06472284, a NA study of Surgery, is active but no longer recruiting, sponsored by Joseph D. Tobias.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.

Conditions Studied

Interventions

  • DEVICE TetraGraph

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-09-12
Est. Completion 2026-02
Phase NA

Sponsor

Joseph D. Tobias

21 total trials

What the Registry Record Tells You About NCT06472284

The ClinicalTrials.gov registry entry for NCT06472284 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Joseph D. Tobias, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which TetraGraph is the first listed.

NCT06472284 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06472284 about?

NCT06472284 is a clinical study titled "TetraGraph in Rocuronium Infusions". This is a prospective, non-blinded study to evaluate rocuronium infusion requirements using the TetraGraph Neuromuscular Transmission Monitor during surgical procedures in patients less than 18 yrs. of age.

What is the current status of trial NCT06472284?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-09-12. Estimated completion is 2026-02.

What conditions does trial NCT06472284 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT06472284?

The interventions under investigation include: TetraGraph (DEVICE).

Who is sponsoring clinical trial NCT06472284?

This trial is sponsored by Joseph D. Tobias, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06472284 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.